First COPD triple therapy recommended for PBS listing
By Michael Woodhead
16 Feb 2018
The first triple therapy inhaler for COPD containing a LAMA, LABA and inhaled steroid has been recommended for PBS listing. At its December 2017 meeting the Pharmaceutical Benefits Advisory Committee recommended an Authority Required (Streamlined) listing for GSK’s Trelegy Ellipta inhaler, which contains umeclidinium and vilanterol with fluticasone. The dry powder inhaler is indicated as ...